Sinus Dilation Devices Market (By Product: Balloon Sinus Dilation Devices, Endoscopes, Sinus Stents/Implants, Functional Endoscopic Sinus Surgery (FESS) Instruments Set, Others; By Type: Sinuscopes, Rhinoscopes; By Procedure: Standalone, Hybrid; By Patient: Adult, Pediatric; By End-use: Hospitals, Ambulatory Surgical Centers, Ent Clinics/in Office) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Sinus Dilation Devices Market
5.1. COVID-19 Landscape: Sinus Dilation Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Sinus Dilation Devices Market, By Product
8.1. Sinus Dilation Devices Market Revenue and Volume, by Product, 2024-2033
8.1.1. Balloon Sinus Dilation Devices
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Endoscopes
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Sinus Stents/Implants
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Functional Endoscopic Sinus Surgery (FESS) Instruments Set
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Others
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Sinus Dilation Devices Market, By Type
9.1. Sinus Dilation Devices Market Revenue and Volume, by Type, 2024-2033
9.1.1. Sinuscopes
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Rhinoscopes
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Sinus Dilation Devices Market, By Procedure
10.1. Sinus Dilation Devices Market Revenue and Volume, by Procedure, 2024-2033
10.1.1. Standalone
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Hybrid
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Sinus Dilation Devices Market, By Patient
11.1. Sinus Dilation Devices Market Revenue and Volume, by Patient, 2024-2033
11.1.1. Adult
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Pediatric
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global Sinus Dilation Devices Market, By End-use
12.1. Sinus Dilation Devices Market Revenue and Volume, by End-use, 2024-2033
12.1.1. Hospitals
12.1.1.1. Market Revenue and Volume Forecast (2021-2033)
12.1.2. Ambulatory Surgical Centers
12.1.2.1. Market Revenue and Volume Forecast (2021-2033)
12.1.3. Foundries
12.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 13. Global Sinus Dilation Devices Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.1.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.1.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.1.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.1.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.1.6.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.1.6.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.7.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.1.7.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.1.7.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.1.7.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.2.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.2.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.2.7. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.2.8. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.9.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.9.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.2.10. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.2.11. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.12.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.12.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.2.12.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.2.13. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.14.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.2.14.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.2.14.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.2.15. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.3.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.3.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.3.6.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.3.7. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.8.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.3.8.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.3.9. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.10.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.10.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.3.10.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.3.10.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.11.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.3.11.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.3.11.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.3.11.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.4.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.4.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.4.6.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.4.7. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.8.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.4.8.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.4.9. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.10.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.10.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.4.10.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.4.10.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.11.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.4.11.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.4.11.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.4.11.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.5.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.5.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.5.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.5.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.5.6.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.5.7. Market Revenue and Volume Forecast, by End-use (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)
13.5.8.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)
13.5.8.4. Market Revenue and Volume Forecast, by Patient (2021-2033)
13.5.8.5. Market Revenue and Volume Forecast, by End-use (2021-2033)
Chapter 14. Company Profiles
14.1. Smith+Nephew
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Stryker
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Intersect ENT, Inc
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Olympus Corporation
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. SinuSys Corporation
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Johnson & Johnson Services, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. TE Connectivity
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. InnAccel Technologies Pvt Ltd
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client